Skip to main navigation Skip to search Skip to main content

BRE-41 Supplemental Budget: Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Advanced Breast Ca

  • Massarweh, Suleiman (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date4/25/134/30/15